Substance / Medication

Pazopanib hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The value of a second expert opinion in histopathological diagnosis of bone and soft tissue sarcoma: a systematic review.
Vu Jennifer, Petrucco Claudia, Vargas Cristina et al. · Pathology · 2026
PMID: 41390329Meta-Analysis
Safety and efficacy of cryoablation of soft-tissue tumours: a systematic review.
Bodard Sylvain, Marcelin Clement, Kastler Adrian et al. · Br J Radiol · 2025
PMID: 38588564Meta-AnalysisFull text (PMC)
Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcoma: A Systematic Review.
Joyce Ronan, Herlihy Emer, Lavan Naomi et al. · Int J Radiat Oncol Biol Phys · 2025
PMID: 39111455Meta-Analysis
Precision medicine in diagnosis, prognosis, and disease monitoring of bone and soft tissue sarcomas using liquid biopsy: a systematic review.
Smolle Maria Anna, Seidel Markus G, Kashofer Karl et al. · Arch Orthop Trauma Surg · 2025
PMID: 39797974Meta-AnalysisFull text (PMC)
Efficacy of immune checkpoint inhibitors in the treatment of soft tissue sarcoma: A systematic review and meta-analysis of clinical trials.
Cao Yang, Wang Wei, Xu Hairong et al. · Int Immunopharmacol · 2025
PMID: 39826454Meta-Analysis
AI in radiological imaging of soft-tissue and bone tumours: a systematic review evaluating against CLAIM and FUTURE-AI guidelines.
Spaanderman Douwe J, Marzetti Matthew, Wan Xinyi et al. · EBioMedicine · 2025
PMID: 40118007Meta-AnalysisFull text (PMC)
High-intensity focused ultrasound treatment of unresectable soft tissue sarcoma and desmoid tumours - a systematic review.
Chetan M, Gillies M, Rehman S et al. · Clin Radiol · 2025
PMID: 40570819Meta-Analysis
Balancing the dose: A meta-analysis of preoperative radiotherapy strategies for soft tissue sarcomas.
Foppele G F, Fiocco M, van Riet B H G et al. · Radiother Oncol · 2025
PMID: 40618897Meta-Analysis
Performance of Radiomics and Deep Learning Models in Predicting Distant Metastases in Soft Tissue Sarcomas: A Systematic Review and Meta-analysis.
Mirghaderi Peyman, Valizadeh Parya, Haseli Sara et al. · Acad Radiol · 2025
PMID: 40651923Meta-Analysis
[Calcifying Aponeurotic Fibroma, a Rare Benign Entity to Consider: a Systematic Review of Literature].
Otera Simone, Bizzarri Martina, Pernazza Angelina et al. · Acta Chir Orthop Traumatol Cech · 2025
PMID: 41502409Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Pazopanib hydrochloride (substance)
SNOMED CT
735169009
UMLS CUI
C1882305

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.